Morpholine → HCID 68839845, 화합물
반응식
[F:1][C:2]1[C:7]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[CH:21]=[CH:20][C:19]([C:22]([F:25])([F:24])[F:23])=[CH:18][CH:17]=3)[CH2:12][CH2:11]2)=[O:9])=[C:6](F)[CH:5]=[CH:4][C:3]=1[S:27]([NH:30][CH3:31])(=[O:29])=[O:28].[NH:32]1[CH2:37][CH2:36][O:35][CH2:34][CH2:33]1>>[F:1][C:2]1[C:7]([C:8]([N:10]2[CH2:11][CH2:12][N:13]([C:16]3[CH:21]=[CH:20][C:19]([C:22]([F:25])([F:24])[F:23])=[CH:18][CH:17]=3)[CH2:14][CH2:15]2)=[O:9])=[C:6]([N:32]2[CH2:37][CH2:36][O:35][CH2:34][CH2:33]2)[CH:5]=[CH:4][C:3]=1[S:27]([NH:30][CH3:31])(=[O:29])=[O:28]참가 물질
3
실험 절차
The title compound was prepared according to the procedure described for example 202 from 2,4-Difluoro-N-methyl-3-[4-(4-trifluoromethyl-phenyl)-piperazine-1-carbonyl]-benzenesulfonamide (example CD) and morpholine to yield the title compound as a colourless foam, MS (m/e): 529.3 (M+H, 100%).
후처리
- customThe title compound was prepared
출처 및 근거
- ORD 기록
- ord-6458fd7737ef4433b51e6ef6cb0cde08